Clinical Trial Update: A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1a/1b safety study of EZN-4176 in adults with castration-resistant prostate cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• EZN-4176

Snippet

Sponsor: Enzon Pharmaceuticals, Inc. | Conditions: Prostatic Neoplasm | Phase 1 | Status: SUSPENDED